$0.569
-0.011 (-1.91%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
CTXR-Prognose durch Analyse ähnlicher Charts
Alphio's CTXR stock price prediction model matches the current Citius Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.58 (+2.07%). The 1-week path is $0.59 (+3.35%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Citius Pharmaceuticals Inc-Aktien kaufen?
Citius Pharmaceuticals Inc is a good buy right now due to its recent revenue growth of $7.1 million in Q3 2026, reflecting a significant market acceptance of its product LYMPHIR. Additionally, the gross margin for Q1 2026 was an impressive 79.99%, indicating strong profitability potential. However, the main risk is the net loss of $28.11 million reported in Q2 2026, which raises concerns about financial sustainability.
CTXR schloss am Tuesday bei $0.57, nachdem der Kurs -1.91% fallen
Citius Pharmaceuticals Inc (CTXR) last closed at $0.5691, losing -1.91%. These facts feed the 1-day and 1-week CTXR price prediction above.
Analystenkonsens
Citius Pharmaceuticals Inc (CTXR): 1 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Citius Pharmaceuticals Inc (CTXR) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf CTXR am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für CTXR
Historically the probability of a positive September return for CTXR is 0.00%. April offers the highest probability of a positive month at 28.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.